Company intelligence / Profile preview

Broadgate Advisers

Ownership: Private
Development stage: Other

Overview

Broadgate Advisers is an international advisory firm specializing in M&A advisory, venture capital, and wealth management. It operates as a subsidiary of Malta-based BA Capital Holding PLC. The firm has advised on significant transactions in the healthcare sector—most notably advising Boston Oncology Arabia on a $35 million investment from TVM Capital Healthcare—but does not itself develop or manufacture therapeutics.

Industry: Investors

Partnerships

No direct pharmaceutical or biotech partnerships as an operator; acts as advisor to companies in these sectors

Beyond the preview

Go deeper on Broadgate Advisers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broadgate Advisers.

Explore the full profile